Lecumberri, R <br/><br/>
Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: results from the ABEL study.  [electronic resource] 

 -  Thrombosis research  2013 
 - 666-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-2472 
<br/><br/><label>Standard No.: </label>10.1016/j.thromres.2013.09.026  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticoagulants--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carboplatin--administration & dosage<br/>Chemotherapy, Adjuvant<br/>Cisplatin--administration & dosage<br/>Disease-Free Survival<br/>Etoposide--administration & dosage<br/>Female<br/>Hemorrhage--drug therapy<br/>Heparin, Low-Molecular-Weight--adverse effects<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Small Cell Lung Carcinoma--drug therapy<br/>Survival Analysis<br/>Treatment Outcome